# Mayo Clinic multi-cancer detection observational cohort

Source: https://onco.cc/trials/mayo-mcd-cohort/  
OnCo record `mayo-mcd-cohort` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A Mayo Clinic study of how multi-cancer blood tests are used in everyday practice and what people think of them.

## Summary

Mayo Clinic multi-cancer detection observational cohort (NCT06962995) is an observational study sponsored by Mayo Clinic with National Cancer Institute (NCI). It assesses the incorporation of multi-cancer detection testing into clinical practice, with research blood draws and surveys on attitudes and beliefs.

The registry record, read on 29 October 2026, gives its status as recruiting, with an estimated 1,000 participants, a start on 7 May 2025 and primary completion expected on 30 June 2029.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-10-29
- Registry id: NCT06962995
- Phase: observational
- Setting: Patients at Mayo Clinic sites offered multi-cancer detection testing in practice, with blood samples and surveys
- Sponsor: Mayo Clinic with National Cancer Institute (NCI)
- Enrolled: 1000

## Sources

- ClinicalTrials.gov NCT06962995: https://clinicaltrials.gov/study/NCT06962995

## Connected records

- fronts: [Early Detection & Screening](https://onco.cc/fronts/early-detection/)
- technologies: [Liquid biopsy (ctDNA)](https://onco.cc/technologies/liquid-biopsy/), [Multi-cancer early detection (MCED)](https://onco.cc/technologies/mced/)
- institutions: [Mayo Clinic](https://onco.cc/institutions/mayo-clinic/), [National Cancer Institute (NIH)](https://onco.cc/institutions/nci/)

---
JSON: https://onco.cc/api/v1/entities/mayo-mcd-cohort.json